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Abstract 
Background: Biological production of the aromatic compound para-aminobenzoic acid (pABA) is of great interest to 
the chemical industry. Besides its application in pharmacy and as crosslinking agent for resins and dyes pABA is a poten-
tial precursor for the high-volume aromatic feedstocks terephthalic acid and para-phenylenediamine. The yeast Saccha-
romyces cerevisiae synthesises pABA in the shikimate pathway: Outgoing from the central shikimate pathway intermedi-
ate chorismate, pABA is formed in two enzyme-catalysed steps, encoded by the genes ABZ1 and ABZ2. In this study S. 
cerevisiae metabolism was genetically engineered for the overproduction of pABA. Using in silico metabolic modelling 
an observed impact of carbon-source on product yield was investigated and exploited to optimize production.
Results: A strain that incorporated the feedback resistant ARO4K229L and deletions in the ARO7 and TRP3 genes, 
in order to channel flux to chorismate, was used to screen different ABZ1 and ABZ2 genes for pABA production. In 
glucose based shake-flaks fermentations the highest titer (600 µM) was reached when over-expressing the ABZ1 and 
ABZ2 genes from the wine yeast strains AWRI1631 and QA23, respectively. In silico metabolic modelling indicated 
a metabolic advantage for pABA production on glycerol and combined glycerol-ethanol carbon-sources. This was 
confirmed experimentally, the empirical ideal glycerol to ethanol uptake ratios of 1:2–2:1 correlated with the model. A 
13C tracer experiment determined that up to 32 % of the produced pABA originated from glycerol. Finally, in fed-batch 
bioreactor experiments pABA titers of 1.57 mM (215 mg/L) and carbon yields of 2.64 % could be achieved.
Conclusion: In this study a combination of genetic engineering and in silico modelling has proven to be a complete 
and advantageous approach to increase pABA production. Especially the enzymes that catalyse the last two steps 
towards product formation appeared to be crucial to direct flux to pABA. A stoichiometric model for carbon-utiliza-
tion proved useful to design carbon-source composition, leading to increased pABA production. The reported pABA 
concentrations and yields are, to date, the highest in S. cerevisiae and the second highest in a microbial production 
system, underlining the great potential of yeast as a cell factory for renewable aromatic feedstocks.
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Background
Significance of bio‑derived aromatic feedstocks 
for chemical industry
Microbial metabolic pathways give rise to many com-
pounds that can potentially substitute currently petroleum 
based chemicals with bio-derived ones or replace them 
with bio-based alternatives. Using metabolic engineering 
these capabilities are already being exploited to create new 
organisms that use abundant and renewable feedstocks 
to efficiently produce an expanding spectrum of valuable 
chemicals [1–3]. Recent advances in metabolic engineer-
ing of Saccharomyces cerevisiae have shown that systems 
and synthetic biology tools nowadays allow rational con-
struction of capable production strains [4–6]. In particular 
aromatics have great potential for bio-based production as 
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the shikimate pathway gives rise to a wealth of aromatics 
and derived compounds, with diverse applications in dif-
ferent industries, including the chemical one [7–12].
The shikimate pathway intermediate para-aminoben-
zoic acid (pABA) is one of these aromatics with versatile 
applicability, it is already being used use as crosslinking 
agent for resins and dyes, as a precursor in the pharma-
ceutical industry and as a therapeutic itself (e.g. for the 
drug POTABA®). However it has so far not been applied 
as bulk feedstock for large scale application in the plas-
tic and fibre industry, likely because it is not price-com-
petitive compared to other precursors that are readily 
available from chemical synthesis. This may change once 
a competitive bio-based production has been estab-
lished: It has recently been demonstrated that pABA can 
be chemically converted to terephthalic acid [13] mak-
ing it a potential bio-feedstock for polyethylene tereph-
thalate (PET) production. PET is used for packaging as 
well as clothing and recently also in the auto industry 
[14]. The global market volume for PET packaging was 
nearing 16 Mt valued at 48.1 billion USD in 2014 [15]. 
This is expected to rise to 19.9 Mt and 60 billion USD in 
2019 [15]. The global market volume for bio-based PET 
exceeded 540 kt in 2012 and is expected to rise sharply 
till 2020, with a doubling in 2015 and a tripling in 2016 
in respect to 2014. While current bio-based PET is 
claimed to be up to 30 % sustainable [16] in fact only the 
monoethylene glycol share of the copolymer is derived 
from renewable feedstocks, while the terephthalic acid 
component, the major part of PET by volume and cost, 
is still petroleum based. Therefore industrial interest to 
develop a fully sustainable PET product is high and sub-
stantial investments are being made in order to establish 
bio-based terephthalic acid production [14, 17, 18].
pABA may also be chemically converted to para-phe-
nylenediamine (e.g. via Kochi- or Hunsdiecker reaction 
followed by nucleophilic substitution), which is (besides 
terephthalic acid) the second building block of the ara-
mid fibre Kevlar®. Global demand for these materials, 
which combine high strength with low weight as well as 
chemical and heat resistance properties, was estimated to 
74.5 kt in 2014 and is expected to rise to 110 kt in 2020 
with an estimated value of 4.7 billion USD [19].
Aromatic compounds derived from yeast shikimate 
pathway
pABA is naturally produced by yeast as an intermediate 
in the shikimate pathway, the central metabolic route 
leading to formation of the aromatic amino acids phe-
nylalanine, tyrosine and tryptophan [20]. The pathway 
is simplistically reproduced in Fig.  1: The intermediates 
of glycolysis and pentose phosphate pathway, phospho-
enol pyruvate (PEP) and erythrose 4-phosphate (E4P), 
respectively, enter the pathway through a series of con-
densation and redox reactions that yield the intermedi-
ate shikimate. Shikimate is subsequently converted to 
the central branch point metabolite chorismate under 
ATP hydrolysis and introduction of a second PEP. Out-
going from chorismate the aromatic amino acids and 
pABA are synthesised, the latter being a precursor for 
folate metabolism [21]. The synthesis of pABA comprises 
two key enzymes encoded by the genes ABZ1 and ABZ2: 
The gene product of ABZ1 (aminodeoxychorismate syn-
thase) transfers an amino-group from glutamine to the 
para-position of chorismate, thus forming glutamate and 
4-amino-4-deoxychorismate. The gene product of ABZ2 
(aminodeoxychorismate lyase) then cleaves the ester-
bond between the ring and the C3-body releasing pyru-
vate and pABA.
Regulation of the shikimate pathway in S. cerevisiae is 
manifold [22] and yet to be fully understood. It is tightly 
controlled by its end-products, foremost by inhibition 
of its initial step by phenylalanine and tyrosine [23]. 
However a point mutation in the ARO4 gene (leading 
to a changed amino acid sequence, ARO4K229L) has been 
reported that makes the gene product largely resistant to 
feedback inhibition [23].
Despite the biosynthesis route to pABA being present 
in S. cerevisiae, common laboratory strains like S288c 
and CEN.PK derived ones, suffer a growth deficit if 
pABA is omitted from media, supposedly due to reduced 
functionality of the ABZ1 gene [24]. In the comparative 
study that examined this, it was also found that the wine 
yeast EC1118 carries a more functional version of this 
gene [24]. In fact, a previous study on pABA production 
in S288c showed that overproduction could be achieved 
using the ABZ1 gene from the wine yeast AWRI1631, 
which is identical to the one of EC1118 [9]. The study 
identified yeast as suitable host, with regard to in silico 
determined theoretical maximum yields (0.53  g/gGlucose) 
and in  vivo toxicity limits (50  % growth rate reduction 
at 0.62 g/L) [9]. However, the production was moderate 
(250  µM), raising the question, if ABZ2 might be cur-
rently limiting pABA production in yeast. Recently over-
production was reported in E. coli (4.8  g/L) where also 
the choice of the bacterial analogues to ABZ1 and ABZ2 
(pabA & pabB/pabAB and pabC) was shown to be crucial 
[25].
In the present study overproduction of pABA in S. cer-
evisiae from different carbon-sources is improved using 
genetic engineering and metabolic modelling. In particu-
lar the metabolic bottleneck to pABA formation from 
chorismate and the use of glycerol as an alternative car-
bon-source were investigated. Glycerol is a by-product 
of both the biodiesel and the bioethanol industries and is 
considered an inexpensive and sustainable feedstock that 
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does not directly compete with resources of food indus-
try [26, 27]. In this study a mixed glycerol-ethanol (GLY/
ETH) feed with a high glycerol-share was used to maxi-
mize pABA production and yield.
Results and discussion
Designing a strain for pABA production—screening 
of different ABZ1 and ABZ2 genes
The production of pABA in S. cerevisiae requires diver-
sion of carbon flux towards pABA synthesis through 
elimination of competing metabolic pathways and 
enhancement of pABA synthesis through over-expres-
sion of key enzymes. Therefore the TRP3 and ARO7 
genes were deleted and the feedback inhibition resistant 
ARO4K229L gene was introduced, in order to overcome 
product inhibition and increase flux to the shikimate 
pathway [8, 10, 12].
The resulting genetically modified base strain “PABA0” 
(cf. Fig. 1; “Strain and plasmid construction” section) was 
used as a chassis cell to screen different alleles of ABZ1 
and ABZ2 for their effect on pABA production. To start 
with, sequences were compared in silico, by means of the 
alignment of the 43 different ABZ1 and ABZ2 nucleo-
tide and amino acid sequences, derived from SGD (www.
yeastgenome.org). With the aim to cover the greatest 
possible variety, the alleles of the lab yeast (S288c) and 
three wine yeasts (AWRI1631, AWRI796, QA23) were 
chosen. These ABZ1 and ABZ2 genes were compared 
in detail regarding sequence similarities and differences 
(Fig. 2; cf. Additional file 1 for full sequence analysis).
The ABZ1 genes (Fig.  2a) distinguished not only by 
SNPs, but also appeared in different ORFs. So did the 
ABZ2 genes, furthermore it was found that the region 
upstream of the annotated ORF of ABZ2AWRI1631 coin-
cides with the nucleotide sequence present on the 
genome of AWRI796. This means that the full ORF of 
ABZ2AWRI796 is present also in AWRI1631. This may indi-
cate a false annotation of either gene. Therefore both 
possible ORFs (cf. Fig.  2b) were included for screen-
ing, the putatively falsely annotated gene is referred to 
as ABZ2AWRI1631½ (which corresponds to the original 
annotation of ABZ2AWRI1631) the other one as ABZ2AW-
RI1631full (which corresponds to the original annotation 
of ABZ2AWRI796). The yeast strain Lalvin QA23 provided 
other substantially different ABZ1 and ABZ2 genes. All 
four ABZ2 genes and the ABZ1 genes of AWRI1631 and 
QA23 were chosen for in vivo comparison.
The strains “PABA1”—“PABA5” (cf. “Strain and plas-
mid construction” section), which over-expressed the 
different ABZ1 & ABZ2 genes, were compared in shake-
flask experiments with the aim to find the best set of 
ABZ1 and ABZ2 genes for high pABA production (Fig. 3). 
Fig. 1 Simplified shikimate pathway including modifications for pABA production. Knock-out targets are highlighted red, (over)expression targets 
green. The central intermediates are: 3-deoxy-d-arabino-heptulosonate-7-phosphate (DAHP), 3-dehydroquinate (DHQ), 3-dehydroshikimate (DHS), 
shikimate, shikimate-3-phosphate (S3P), chorismate, phenylalanine (PHE), tyrosine (TYR), tryptophan (TRP) and para-aminobenzoate (pABA). 
Important genes and the respective enzymes involved are: ARO3/ARO4: 3-deoxy-d-arabino-heptulosonate-7-phosphate (DAHP) synthase, ARO7: 
chorismate mutase, TRP2: anthranilate synthase, TRP3: indole-3-glycerol-phosphate synthase, ABZ1: aminodeoxychorismate synthase, ABZ2: amino-
deoxychorismate lyase
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PABA0 already exhibited baseline pABA production 
in respect to the background strain (CEN.PK113-5D), 
indicating that the modifications so far already directed 
flux towards pABA, even without increased expression 
of ABZ1 and ABZ2. This was supported by the observa-
tion that the strain grew without supplementary pABA 
(cf. “In vivo restrictions of carbon-source utilization and 
impact on aromatic product spectrum” section). Over-
expression of ABZ1 and ABZ2 led in all cases to pABA 
production higher than from the base strain PABA0. The 
highest production was achieved by the combination of 
ABZ1AWRI1631 and ABZ2QA23, which showed a ~35-fold 
increase in the pABA concentration compared to PABA0. 
Further it can be noted that the full ABZ2AWRI1631 gene 
Fig. 2 Simplified depiction of the alignment of ABZ1 (a) and ABZ2 (b) amino acid sequences. Amino acid residues unique to a certain sequence are 
indicated in green. Sequences are shown from N-terminus to C-terminus
Fig. 3 Production of pABA in shake flask experiments of S. cerevisiae strains. WT = CEN.PK113-5D, PABA0 = CEN.PK113-5D Δtrp3 Δaro7 ARO4K229L. 
PABA1–PABA5 are based on PABA0, with over-expression of additional ABZ1 and ABZ2 alleles on a plasmid expression vector as indicated on the 
figure (for full genotype cf. “Strain and plasmid construction” section)
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in PABA3 led to a higher production than the truncated 
version expressed in strain PABA2. Finally, PABA5, har-
bouring ABZ1QA23 in combination with ABZ2QA23, was 
inferior compared to PABA2, PABA3 and PABA4.
It is evident that a connection between pABA produc-
tion and gene sequences exists. Inferred from the mar-
ginal pABA production of strain PABA1 it appears that 
not only the ABZ1 but also the ABZ2 gene of S288c and S. 
cerevisiae strains with an identical sequence has reduced 
functionality. The most obvious explanation seems to be 
that the two differences in the amino acid sequence of 
ABZ2S288c in respect to ABZ2AWRI796 (cf. Fig.  2) reduce 
the functionality of the enzyme. With PABA3 producing 
nearly twice the amount of pABA compared to PABA2 it 
is evident that ABZ2AWRI1631 was annotated falsely in the 
AWRI1631 genome, and the larger ORF (correspond-
ing to ABZ2AWRI796) is the correct one. When including 
PABA4 in the comparison ABZ2QA23 appears to excel in 
pABA production. Comparing its sequence to the other 
genes it seems very likely that a relation between the 
unique N-terminus of ABZ2QA23 and its effect on pABA 
production exists. Comparing PABA4 to PABA5 shows 
that also the choice of ABZ1 has a great influence, as only 
combining ABZ1AWRI1631 with ABZ2QA23 allowed greatly 
increased pABA titers. It seems likely that ABZ1QA23 is 
dysfunctional due to the 5′-end truncation of the gene.
The differences that arise for pABA production may not 
be only due to differences in activity of these enzymes but 
also enzyme concentration. This may involve more com-
plex regulation on transcriptional and translational levels 
like e.g. codon usage or mRNA stability [28]. Therefore 
expression levels were examined by measuring the level 
of target gene mRNA using RT-qPCR. mRNA levels of 
the different ABZ1 and ABZ2 genes in the production 
strains were compared to the background strain with no 
ABZ1 and ABZ2 over-expression (Table  1). In all over-
expressing strains significantly increased mRNA lev-
els of the ABZ genes were found, which correlates with 
the observed higher pABA production. By relating the 
abundance of transcript of the different genes to pABA 
production in the different strains, conclusions towards 
their activity can be drawn. It can be hypothesized that 
ABZ1AWRI1631 codes for a more active enzyme than 
ABZ1QA23, as mRNA levels of ABZ1AWRI1631 are signifi-
cantly lower, but the gene leads to significantly higher 
pABA production. Further the putatively high expression 
of ABZ2S288c and ABZ2AWRI1631½ but low pABA produc-
tion in strains carrying these genes indicate low activity. 
In reverse this indicates higher activity of ABZ2AWRI1631 
full as it leads to higher pABA production although its 
transcript is least abundant. The obtained maximum 
pABA production from ABZ2QA23 may however be due 
to its higher expression. Therefore, the codon usage of 
the different ABZ genes was compared (cf. Additional 
file 1) in order to validate the relevance of mRNA levels 
for assessment of gene expression. However no major dif-
ferences could be found that would indicate greatly dif-
ferent strength of translation of the ABZ transcripts.
Finally, relating ligand binding sites to the mutations in 
amino acid sequences of the different ABZ genes could 
allow conclusions towards enzyme functionality to be 
drawn (Additional file  1) and may explain the greatly 
improved performance of certain genes.
In silico analysis of carbon‑source composition leads 
to enhanced pABA production in vivo
During characterization experiments of the PABA strains 
it could be observed that the production of pABA was 
higher later in the fermentation, when glucose was 
depleted and glycerol & ethanol were reassimilated (cf. “In 
vivo restrictions of carbon-source utilization and impact 
on aromatic product spectrum” section). To understand 
this phenotype in silico modelling was used: Elementary 
mode analysis was performed [29], in order to compare 
biomass and product carbon-yields on the substrates glu-
cose, glycerol, ethanol and glycerol + ethanol. The achiev-
able maximum carbon yield for pABA from ethanol is 
generally lower than from glucose or glycerol, while glyc-
erol allows a higher theoretical pABA yield than glucose 
(Table 2; cf. Additional file 2 for distribution of elementary 
flux modes). The highest possible carbon yield for pABA 
with and without biomass formation, can be achieved in 
silico from a combination of glycerol and ethanol as feed, 
which may explain our experimental observation of high 
pABA formation in the second fermentation phase when 
reutilization of ethanol and/or glycerol occurs.
The analysis of the product carbon yields from all ele-
mentary modes on GLY/ETH-feed allowed the deter-
mination of an ideal ratio between glycerol and ethanol. 
Figure 4 shows that the majority of feasible flux distribu-
tions feature a GLY:ETH ratio lower than 10, while the 
highest product yields are obtained with GLY:ETH ratios 
between 0.5 and 2 (magnified area in Fig. 4).
Increased maximum yield using glycerol as carbon-
source (compared to glucose) can be explained with 
Table 1 Relative mRNA levels of  the different over-





Gene/origin Background S288c AWRI1631 QA23
ABZ1 0.2 ± 0.0 NA 12 ± 3 60 ± 12
ABZ2 0.5 ± 0.1 175 ± 44 201 ± 28a/16 ± 4b 119 ± 0
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additional reducing power (FADH2) gained during glyc-
erol metabolization (reaction R11b, Additional file  2), 
which can be used to regenerate ATP. The initial step of 
ethanol utilization (reaction R10c, Additional file 2) also 
reduces an extra redox co-factor (NADH); however on 
ethanol alone very limited metabolic freedom exists, as 
all flux to upstream pathways (glycolysis, pentosephos-
phate pathway, shikimate pathway) has to be derived 
from acetyl-CoA via phosphoenolpyruvate carboxykin-
ase (reaction R41c, Additional file  2) and malic enzyme 
(reaction R62c, Additional file 2). In particular for forma-
tion of the shikimate pathway precursor PEP from etha-
nol, two more mol ATP are required in respect to glucose 
and four more in respect to glycerol.
This is compensated on a combined GLY/ETH-feed: 
Separate carbon flow to the upper and lower parts of 
central metabolism allows full advantage of higher avail-
ability of reduced redox equivalents, resulting in a higher 
biomass yield and more modes close to the stoichiometric 
limit (line between max. biomass and max. product yield, 
cf. Additional file 2 for biomass vs. product yield plots). 
In addition the majority of modes with low product/bio-
mass formation are abolished, as the two major by-prod-
ucts on glucose (GLY/ETH) are substrates now.
In order to reproduce the observed higher pABA pro-
duction of glucose batches after the diauxic shift (when 
re-utilizing glycerol and/or ethanol) and to test the pre-
diction of the elementary flux mode analysis, the impact 
of the carbon-sources glucose, glycerol, ethanol and 
glycerol + ethanol mixtures was tested in vivo using the 
PABA4 strain in shake-flask experiments. Comparing 
single carbon-sources the pABA titer was found to be 
highest on glucose, the carbon yield however was higher 
on glycerol (Fig. 5a). The product carbon yield from etha-
nol can be noted as lowest, despite a high uncertainty due 
to high evaporation (cf. “Metabolite analysis” section). 
The highest pABA yields and also titers were obtained 
when combining glycerol and ethanol. Therefore different 
Table 2 Theoretical maximum product carbon yields using different substrates
Substrate Glucose Ethanol Glycerol Glycerol + ethanol
Maximum pABA yield (%) 84 75 90 92
Maximum pABA yield with biomass (%) 81 50 86 87
Fig. 4 Distribution of pABA yields in dependence of the glycerol to ethanol ratio in elementary flux modes in a window with a GLY:ETH ratio ≤100 
[C-mol/C-mol]. Each point in the chart corresponds to the specific product carbon yields [%] and substrate ratio of the respective elementary flux 
mode. The insert at the bottom right corner is a magnification of the area in the top left corner where the modes with the highest yields are located
Page 7 of 16Averesch et al. Microb Cell Fact  (2016) 15:89 
concentrations and ratios of glycerol and ethanol were 
tested to determine the ideal ratio of glycerol to ethanol 
(Fig.  5b). It was found that GLY:ETH ratios in the feed 
>3:1  g/g allowed for uptake ratios >0.5  C-mol/C-mol, 
delivering the highest pABA yields. Enforcing an increase 
in uptake ratio only worked up to a certain degree: A 
20:2  g/g GLY:ETH feed-ratio only allowed an uptake 
ratio of 1.1 C-mol/C-mol and while pABA yield was only 
slightly reduced, titer was more than halved.
The results indicate that both, GLY and ETH, are uti-
lized and contribute to pABA production, however in 
different ways. Therefore the contribution of the carbon 
from the two substrates to pABA formation on a com-
bined GLY/ETH carbon-source was investigated in a 
tracer experiment with 1,2-13C labelled ETH and natural 
GLY. Enrichment analysis of pABA revealed the share of 
each substrate’s contribution: In total up to 31 % of pABA 
were derived from GLY (mean enrichment = 69 %). Fur-
ther analysis of the labelling of amino acids revealed that 
glycerol was mainly metabolized in the upper part of gly-
colysis and pentose phosphate pathway, with little to no 
C12-carbon reaching the TCA-cycle (mean enrichment 
of threonine, aspartate and glutamate 92.2, 92.9, 93.9 %, 
respectively). The activity of the threonine aldolase path-
way for glycine biosynthesis could be seen by a glycine 
enrichment of 79.5  %, while serine was only labelled 
59.8 % and clearly was also derived from glycerol. Since 
the alanine enrichment reached 85.2 % it seems that glyc-
erol did not reach the pyruvate pool to a large extent. 
Ethanol finally also reached the pentose phosphate 
pathway and subsequently the biosynthesis of histidine 
(44.1 % enriched) and the aromatics. The fact that etha-
nol served as a precursor for pentose phosphate pathway 
derived compounds points towards a limitation in the 
supply of C3 molecules from the glycerol uptake. During 
the tracer experiment the GLY:ETH uptake ratio was 1.1 
C-mol/C-mol. It is striking that the contribution of etha-
nol to amino acid biosynthesis as well as pABA formation 
(GLY:ETH ratio of 0.47 C-mol/C-mol) was greater than 
the uptake ratio. This means that gluconeogenesis from 
ethanol was active while glycerol was metabolised. This 
could point towards metabolic channelling [30]. Glycerol 
could for instance contribute to a larger extend to synthe-
sis of carbohydrates.
In vivo restrictions of carbon‑source utilization and impact 
on aromatic product spectrum
To characterize the higher in vivo pABA production on 
GLY/ETH in more detail, the metabolic profiles over the 
course of fermentations on GLC and GLY/ETH were 
compared (Fig.  6): On GLC the maximum pABA titer 
was reached only after almost 130 h while a major part 
of pABA was produced during re-assimilation of etha-
nol/glycerol. On GLY/ETH the maximum pABA titer 
Fig. 5 pABA titers (dark grey) and yields (light grey) achieved by PABA4 on different carbon-sources (a) and GLY:ETH different ratios (b). Titers are 
evaporation corrected and represent the maximum after either carbon-source was used up and/or no further product formation occurred. Utilized 
carbon is the amount of C-mol from either carbon-source that was taken up and actually metabolised. Yields and carbon usage ratios are based on 
the evaporation corrected titers while only respecting the actually metabolized fraction of the carbon-source
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was reached within 78 h while the rate of pABA produc-
tion was highest when ethanol was still available (r0–46 h   
=  39.52  μmol/g×h, r46–78  h  =  7.3  μmol/g×h). Albeit 
pABA titer was only slightly higher on GLY/ETH than 
on GLC, productivity was significantly greater (rGLY/ETH   
= 26.7 μmol/g×h, rGLC = 7.2 μmol/g×h).
Further a dependency of the product spectrum on the 
carbon-source could be observed. The major by-product 
was phenylethanol (PEA), which is derived from phe-
nylpyruvate, either as an intermediate of PHE degradation 
or de novo from prephenate (formation of phenylpyru-
vate has been observed in  vivo even though ARO7 was 
knocked out [31]) On glucose PEA titers even exceeded 
pABA titers. However on GLY/ETH formation of PEA 
was reduced (threefold) in favour of increased selectiv-
ity for pABA. Further on GLY/ETH it was observed that 
PEA production early in the fermentation correlated 
directly with the decline of PHE (cf. Additional file  3). 
Tracer experiments showed that growing the strain solely 
on U-13C glucose led to no significant labelling of PEA 
(mean enrichment 3  %) at the end of the exponential 
growth (where PHE was depleted), proving that de novo 
synthesis had not occurred. In stationary phase, however, 
PEA appeared to be partially 13C enriched (mean enrich-
ment 29 %), indicating de novo synthesis from chorismate 
(cf. Additional file  3 for details). No other aromatic by- 
or downstream products of the shikimate pathway were 
found, in particular no accumulation of aromatic amino 
acids was observed. The tryptophan degradation product 
tryptophol was identified in GC–MS samples of the tracer 
experiments but appeared to be unlabelled and hence 
originated from tryptophan degradation only (not de 
novo synthesized). Further dihydrofolate and folate (which 
pABA is a precursor for) were also not found to be present 
in the media in detectable concentrations (LOD < 4 µM).
The advantageous stoichiometry for pABA forma-
tion on GLY/ETH can explain the initial observation 
that a major fraction of pABA production on glucose 
only occurred late in the fermentation after the diauxic-
shift: When glucose was consumed ethanol and glycerol 
were reassimilated, and the major amount of aromatics 
formed. The fact that production and growth only pro-
ceeded until ethanol was depleted indicates that ethanol 
was essential in order to sustain a viable metabolism of 
the cell. This, together with the clues from EMA and the 
tracer experiments, can explain the observed “sweet-spot” 
of the GLY:ETH ratio for pABA production: Ethanol con-
centration has to be limited in order to not dominate car-
bon supply for the cell (due to faster utilization kinetics) 
but apparently also needs to be high enough to support 
metabolism and allow sufficient glycerol utilization. The 
in vivo determined ideal glycerol to ethanol uptake-ratio 
of 0.5  C-mol/C-mol, which delivered the highest pABA 
yields, also correlates with the optimum ratio (between 
0.5 and 2  C-mol/C-mol) predicted by modelling. Inter-
estingly, further enforcing higher glycerol uptake affected 
Fig. 6 Time course of substrate consumption and product formation of biomass main aromatic products on GLC (a) and GLY/ETH (b). Titers are cor-
rected for evaporation of H2O to reflect comparable metabolite concentrations. Carbon sources were 20 g/L glucose (initial 0.666 C-mol, of which 
0.615 were consumed) in (a) and 15 g/L ethanol + 5 g/L glycerol (initial 0.722 C-mol, of which 0.225 were consumed) in (b). Biomass is reflected by 
means of the OD at 660 nm. Growth rates in the exponential phase were µ = 0.2242 h−1 on glucose and µ = 0.1081 h−1 on glycerol/ethanol
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pABA titer negatively and also slightly diminished the 
yield. This was most likely due to the impaired glycerol 
uptake mechanism of laboratory yeast [32], presumably 
resulting in an imbalanced metabolism of the cell if etha-
nol share in the carbon-source is too low.
To maximize pABA production a fed-batch biore-
actor experiment with a high starting cell density was 
conducted. A continuous feed-stream was supposed to 
counteract stagnation of growth due to degradation of 
abundant aromatic amino acids and to further improve 
pABA production and yield. This also intended to explore 
if higher GLY utilization could be achieved by limiting 
ETH availability. In theory this would compensate for 
slower kinetics of GLY uptake and minimize ETH loss by 
evaporation. Utilization of a greater share of GLY while 
minimizing ETH usage was also anticipated to benefit 
product yield (cf. “In vivo restrictions of carbon-source 
utilization and impact on aromatic product spectrum” 
section). Using an ETH-feed rate similar to the observed 
ETH uptake rate (cf. “Strain cultivation” section for 
process details) stripping of ETH was successfully min-
imized, while upholding GLY utilization (7.4  % con-
sumed) as can be seen from Fig.  7. Notably the highest 
GLY utilization and also growth was observed towards 
the end of the fermentation, when ethanol concentra-
tion peaked, due to increased feed rate. This allowed the 
highest pABA titer (1.57 mM) and carbon yield (2.64 %) 
in this study to be reached (Table 3). Besides that, up to 
100 µM pHBA were also detected. Further the PEA titer 
could be successfully minimized, which benefited the 
fraction of pABA (>83 % by titer in mM) of total aromat-
ics. The sharply increasing PEA titer in the initial hours 
largely corresponded to the decline of initial PHE in the 
medium (data not shown), this correlated with the results 
from the tracer experiments, where most PEA on GLY/
ETH was derived from PHE degradation and little to no 
PEA being formed de novo. The steady supply of aro-
matic amino acids in the feed phase enabled the use for 
growth rather than degradation, as can be seen by a con-
stant drop in the levels of PEA, while no accumulation of 
amino acids could be observed (data not shown). 
Carbon‑source utilization helps to balance aromatics 
production
It was recently shown that ethanol stress reduced the 
production of the aromatic amino acids higher alco-
hols, including PEA [33]. This was believed to happen 
via upregulation of the genes ARO8, ARO9 and ARO10. 
However these genes evoke in combination the for-
mation of PEA only via catabolism of aromatic amino 
acids, which can in the present study not fully explain 
the observed accumulation of PEA. We recently demon-
strated that the conversion of chorismate to prephenate/
phenylpyruvate in a ∆aro7 strain proceeds also spon-
taneously [31], the reaction rate is merely a matter of 
substrate and product concentrations, temperature and 
pH. Assuming that pABA production is kinetically lim-
iting, in a situation of high flux into the shikimate path-
way, chorismate could be accumulating, leading to an 
overflow into PEA. A similar flux overflow resulting in 
accumulation of PHE and TYR has been reported when 
producing pABA in E. coli [25]. During growth on GLY/
ETH overall conversion rates are lower, including the 
shikimate pathway. Thus the lower flux into the choris-
mate pool improves balancing with the flux into pABA 
production and chorismate does not overflow into PEA. 
Hereby the introduction of the alternative carbon sources 
helps to balance the pABA synthesis pathways.
Current pABA production appears to be constrained 
by GLY utilization: If growth is limited (either by means 
of low ETH concentrations or depletion of aromatic 
amino acids) then GLY is hardly utilized. If ETH and 
aromatic amino acids are present in excess, more GLY is 
utilized, but flux overflow and degradation of aromatic 
amino acids also diverts carbon to PEA and more ETH 
is lost via evaporation. The uptake of GLY in S. cerevisiae 
laboratory strains has been described as partially defec-
tive and can be improved through over-expression of 
STL1, GUT1CBS6412-13A and GUT2 [32]. This could help to 
not only enhance growth but also production on glycerol: 
It may allow reduction of the ethanol share of the carbon-
source, simultaneously reducing process costs and pre-
sumably also resulting in further improved yield while 
utilizing a more sustainable carbon-source.
Conclusions
The observed titer of 1.6 mM pABA is the highest in S. 
cerevisiae reported to date and the second highest in a 
biological system. This demonstrates the potential of 
S. cerevisiae as a microbial cell factory for aromatics. It 
could also be shown that the variability in different ABZ1 
and ABZ2 sequences of sequenced yeast strains has great 
impact on pABA production. Further this study dem-
onstrates the potential of metabolic engineering when 
rationally making use of metabolic modelling and genetic 
engineering: As predicted by modelling it could be shown 
that production of pABA from a combined glycerol-etha-
nol carbon-source was more efficient than from glucose. 
The benefits are twofold: On the one hand stoichiometry 
allowed a higher yield (as predicted by modelling); on the 
other hand kinetic limitations (that otherwise result in 
flux overflow) were reduced resulting in increased selec-
tivity for the desired compound pABA and reduction of 
the overflow metabolite PEA. This allowed a more than 
sixfold increase in product titer and almost eightfold 
increase in yield over the previous benchmark [9]. In the 
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future enhancing glycerol uptake and metabolization 
should help to increase the pABA yield and titer.
Methods
Metabolic network analysis
Metabolic modelling was conducted by means of elemen-
tary mode analysis using EFMTool [34]. The framework 
was modified from what has been described before [29]. 
In particular metabolic networks were amended with 
additional reactions for pABA formation and glycerol/
ethanol uptake. The networks are given in Additional 
file 2.
Media and strain maintenance
Saccharomyces cerevisiae strains were propagated on 
yeast extract peptone dextrose (YPD) medium, 1 litre 
was composed of 10  g yeast extract, 20  g peptone and 
20 g dextrose (d-glucose) in H2O. For strain construction 
the antibiotics G418 (geneticin) and clonNAT (nourseo-
thricin) were added into the medium to final concentra-
tions of 200 and 100  mg/L, respectively. Also for strain 
construction as well as maintenance selective synthetic 
complete medium was used. It was made up from 6.8 g/L 
yeast nitrogen base without amino acids (Y0626 Sigma) 
and 1.92 g/L drop-out supplement without uracil (Y1501 
Sigma) with 20 g/L glucose or 10 g/L glycerol and 30 g/L 
ethanol as carbon-source. Solid media contained 20 g/L 
agar.
For cultivation of yeast chemically defined minimal 
medium (CDM) was used, 1  l was composed of: 2  g 
Fig. 7 Substrate uptake and aromatic product formation over time in a bioreactor fermentation on GLY/ETH with continuous ETH-feed. Profiles of 
consumed substrates have been adjusted/corrected for dilution to reflect actual substrate uptake. Dashed vertical lines indicate activation/increase 
of the feed with CDM + ETH respectively: I = batch-phase, II = 6 mL/h, III = 21 mL/h
Table 3 Maximum titers and  product carbon yields 
of key aromatic compounds and total aromatics obtained 
from batch bioreactor fermentations
Yields are based on dilution/ evaporation corrected concentrations to account 
for actual substrate utilization
a Total aromatics titer is comprised of pABA, PEA, pHBA and tryptophol
b Carbon yields of PEA and total aromatics were estimated to reflect only the de 
novo synthesized fraction
Compound pABA PEA Totala
Titer (mM) 1.57 0.16 1.9/1.67 de novo
(mg/L) 215 19.5 270
Yield (%) 2.64 0b 2.8b
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(NH4)2SO4, 1  g (NH4)2HPO4, 5.28  g NaH2PO4, 0.5  g 
MgSO4·7 H2O, 0.015  g EDTA, 1  g KCl, 0.15  g CaCl2·2 
H2O, 0.85  g Na2HPO4 amended with trace elements 
and vitamins in aqueous solution. Trace elements (per 
1  l H2O): 4.5  mg ZnSO4·7 H2O, 3  mg Fe(III)Cl3·6 H2O, 
1  mg H3BO3, 0.85  mg MnSO4·H2O, 0.4  mg NaMoO4·2 
H2O, 0.3 mg CoCl2·6 H2O, 0.3 mg CuSO4·5 H2O, 0.1 mg 
KI. Vitamins (per 1  l): 3  mg myo-inositol, 1  mg cal-
cium d-pantothenate, 0.3  mg thiamine hydrochloride, 
0.075 mg pyridoxine hydrochloride, 0.0015 mg d-biotin. 
In case of the knock-out strain 76  mg/L tyrosine, phe-
nylalanine and tryptophan were supplemented, while 
for the background strain 0.2 mg/L pABA were essential 
for growth. The pH was adjusted to 6, carbon-sources 
were glucose (GLC) glycerol (GLY), ethanol (ETH) or a 
glycerol-ethanol mix (GLY/ETH) with amounts as given 
in Fig. 4 for the respective experiments. Concentrations 
of carbon-sources where chosen aiming at comparable 
amounts of C-mol, e.g. when using 30 g/L ethanol even in 
case of <50 % substrate loss by evaporation an equivalent 
amount of C-mol as in the glucose experiment was avail-
able over the course of the fermentation. For the tracer 
experiments 20  g/L fully labelled U-13C glucose (Cam-
bridge Isotope Laboratories, Tewksbury, MA) or 2 g/L of 
fully labelled 13C ethanol (99 %, ICON isotopes, Summit, 
NJ) and 20 g/L unlabelled glycerol were used as carbon-
source. Medium for the bioreactor experiment initially 
contained the twofold ammonium source and 20  g/L 
glycerol +  10  g/L ethanol. The feed solution was CDM 
also with the two-fold ammonium source and 10 % etha-
nol (v/v).
Escherichia coli plasmid maintenance strains were 
cultivated in lysogeny broth (LB) supplemented with 
100  mg/L ampicillin. Strains were grown at 30  °C with 
200 rpm orbital shaking. All cryo-cultures were stored in 
25 % glycerol at −80 °C.
Strain and plasmid construction
Strain construction was based on the S. cerevisiae strain 
CEN.PK113-5D. ABZ1 and ABZ2 genes originated from 
different sequenced and commercially available wine 
yeast strains (Table 6). Cloning was routinely conducted 
following standard protocols [35] and using enzymes 
obtained from New England Biolabs to manufacturer 
instructions. In particular Q5® Hot Start High-Fidelity 
DNA polymerase and high-fidelity (HF®) restriction 
endonucleases were used. For sub-cloning the E. coli 
strain DH5α was utilized. Plasmids and PCR products 
were purified using the Thermo Scientific GeneJET Plas-
mid Miniprep and PCR purification kits. Cloned PCR 
products were verified by sequencing (Sanger service by 
AGRF, Brisbane, AU).
The TRP3 deletion was carried out by replacing the tar-
get gene via homologous recombination, integrating the 
natMX antibiotic marker as described in [36] using the 
lithium acetate method to transform the cells [37]. Suc-
cessful integrations/deletions were verified by PCR using 
primers binding inside and outside of the target/marker 
gene (verA–verD) as outlined in [38]. The same principles 
were used for ARO7 deletion/ARO4K229L integration with 
a few differences: After incorporating the point mutation 
in codon 229 of the original ARO4 (as already described 
in [8]), which changes the respective amino acid residue 
from Lys to Leu and renders the protein feedback inhi-
bition resistant, it was cloned onto the plasmid vector 
pCV3. pCV3-ARO4K229L was used directly to obtain an 
integration cassette comprised of the ARO4K229L gene 
fused with the POL4 terminator and the kanMX marker 
that would integrate at the ARO7 locus, thus replac-
ing it and putting the ARO4K229L under control of the 
ARO7 promoter, which not only simplified experimen-
tal efforts but also resulted in a positive feedback loop 
for expression. The constructed strain (CEN.PK113-5D 
Δtrp3::natMX Δaro7::kanMX-ARO4K229L, PABA0) served 
as the host for the pABA expression plasmids.
Plasmid vectors for expression of the genes for pABA 
formation from chorismate were constructed based on 
pSP-G1 [39]. The ABZ1 genes were always cloned to 
the TEF1 promotor’s multi-cloning site, while the ABZ2 
genes were cloned into the PGK1 promotor’s polylinker. 
The primers used to amplify the respective integration/ 
deletion cassettes and cloning inserts were purchased 
from Integrated DNA Technologies, the sequences can 
be found in Table 4. For cloning, standard desalted prim-
ers where used, while for deletion/integration PAGE-
purified primers proved to be significantly more efficient.
Vectors were constructed in a way that allowed conclu-
sive comparison of the different genes against each other 
without having to compare each gene separately. Plas-
mids used in this study are given in Table 5. The plasmids 
were transformed to the PABA0 strain, genotypes of 
the final transgenic production strains (CEN.PK113-5D 
Δtrp3::natMX Δaro7::kanMX-ARO4K229L pSP-G1-ABZ1-
ABZ2, PABA1–PABA5) can be found in Table 6.
Strain cultivation
250  mL Erlenmeyer baffled cell culture vent cap poly-
carbonate flasks (Corning®, Corning, NY) were used 
for shake-flask experiments (culture volume being 10  % 
of total) using a Multitron 3-stack incubation shaker 
with 25  mm shaking throw at 200  rpm (INFORS HT, 
Bottmingen, Schweiz) for incubation of shake-flasks. 
Experiments were carried out in biological triplicates, 
single colonies from solid medium were used to inoculate 
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Table 4 Primers used in this study
Name 5ʹ to 3ʹ sequence 
TRP3 del for GCTGGTCAGTATTAACACATTACCAAATCTGTTTGGTTCTACATAGAA
CGCCCAGCTGAAGCTTCGTACGC 






TRP3 verA GTTCGACAAGGAGCTGGTCAG 
TRP3 verB CAAGCAGGATGGTAGGGACG 
TRP3 verC ACGTCAGTGGAGGCACTTGG 
TRP3 verD TACATGAAGGCGTTCGCCC 
nat verB GAGGTCACCAACGTCAAC 
nat verC GTAAGCCGTGTCGTCAAG 
ARO7 verA CTTTATCGTAAATTTTCAATGG 
ARO7 verD GGTTATTGGGTTGATAATTCCT 
ARO4 verB GTTGAGATTCGGTGGTTCTGGC 
ARO4 verC TTGGCTGATTTGGTCTCCTTCG 
KmR verB TGTACGGGCGACAGTCACAT 
KmR verC GTGTTCCTGCGCCGGTTGC 
ARO7 verA2 CACCTATTGCGCCGCTCGCGGAATACAATTAC 
ARO7 verB GTAATTAACTTCTGGGGCATAAGGCGCC 
ARO7 verC GGTTCTGTTGCCACTAGAGATATAGAATG 
ARO7 verD2 CCAAGACTTTATATGCCAATGGAGGGATAGGCGC 
ABZ1AWRI1631 for BglII CTGAAGATCTAAAAAAATGCTGTCCGATACAATTGAC 
ABZ1AWRI1631 rev SacI AGTCGAGCTCCTACATGAAAATTTGTAAGTTGC 
ABZ1QA23 for BglII CTGAAGATCTAAAAAAATGTCATCTTCTGTGATTAGTG 
ABZ1QA23 rev SacI AGTCGAGCTCCTACATGAAAATTTGCAAGTTGC 
ABZ2S288c for BamHI CTGAGGATCCAAAAAAATGTCACTAATGGACAATTG 
ABZ2S288c rev XhoI AGTCCTCGAGTCAATATTTTGTCTTCACTGTTCCC 
ABZ2AWRI1631 for BamHI CTGAGGATCCAAAAAAATGTTCAACGAAAGGCAATGC 
ABZ2AWRI1631l rev XhoI AGTCCTCGAGTCAATATTTTGTCTTCACTGTTC 
ABZ2QA23 for BamHI CTGAGGATCCAAAAAAATGAACGWATTTTTTTTATTAGATGAAC 







Annealing sites in primers for amplification of integration cassettes are shown in red, while overhangs for homologues recombination have been marker blue. For 
cloning primers the restriction sites are indicated in bold letters
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primary pre-cultures on liquid medium (CDM). After 
overnight growth a secondary pre-culture was inoculated 
to a defined OD660. Cells from log-phase were used to 
inoculate the main-culture to an OD660 of 0.8 in case of 
ABZ1/ABZ2 performance screening on glucose and 0.2 
for all other shake-flask experiments. Growth was moni-
tored by means of OD660 and pH, collecting supernatant 
for analysis every 3  h during exponential growth and 
twice a day in stationary phase (after 9 h in case of GLC, 
after 24 h in case of GLY/ETH).
Fed-batch bioreactor experiments were carried out 
in duplicates using a BIOSTAT® B (Sartorius, Göttin-
gen, Germany). Shake-flask pre-cultures on GLY/ETH 
were kept exponential (by transferring cells from cul-
tures approaching end log-phase to fresh medium, while 
adjusting volume to not exceed a final OD of 5 in order 
to suffice oxygen demand) until enough cells were col-
lected to inoculate 2 × 400 mL medium to an OD of 1.8 
or 4.4 for the respective experiments. Cells were washed 
twice with fresh medium, resuspended in 24 mL thereof 
and transferred into the bioreactors. Feeding was started 
when initial ethanol was nearing depletion (inferred by 
retardation of growth by means of OD). Feed-flow was 
set to 100  µL/min, corresponding to the approximate 
ethanol uptake rate (predetermined in shake-flasks), 
adjusted to the actual OD. In the final stage (cf. Fig.  7) 
the feed was increased by 3.5-fold. Aeration was kept 
at a minimum (0.16  L/min) in order to minimize strip-
ping and foaming. However the system was controlled 
to be aerobic with dissolved oxygen no lower than 80 %. 
Table 5 Plasmids used in this study as template for amplification of deletion markers and over-expressing of heterolo-
gous genes
Name Details Origin
pUG74 PCR template vector, source for loxP-flanked natMX gene deletion marker [40]
pCV3-ARO4K229L ARO4K229L expression vector, source for ARO4K229L–kanMX integration cassette [8]
pSP-G1 Ura+ selectable double expression vector, contains TEF1–PGK1 bidirectional promoter [39]
pSP-G1-ABZ1AWRI1631-ABZ2AWRI1631½ pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 promoter respectively This study
pSP-G1-ABZ1AWRI1631-ABZ2AWRI1631full pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 promoter respectively This study
pSP-G1-ABZ1AWRI1631-ABZ2S288c pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 promoter respectively This study
pSP-G1-ABZ1AWRI1631-ABZ2QA23 pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 promoter respectively This study
pSP-G1-ABZ1QA23-ABZ2QA23 pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 promoter respectively This study
Table 6 Saccharomyces cerevisiae strains used in this study as source of gDNA for production of PCR templates and host 
organism for genetic engineering
Strain Genotype/plasmid Note Origin
S288c MATα SUC2 gal2 mal2 mel flo1 flo8-1  
hap1 ho bio1 bio6
Reference strain, source of ABZ2S288c  
http://www.yeastgenome.org/strain/S288C/overview
[41]
AWRI1631 Wine yeast strain, source of ABZ1AWRI1631, ABZ2AWRI1631full and ABZ2AWRI1631½  
http://www.yeastgenome.org/strain/AWRI1631/overview
[42]
Lalvin QA23 Wine yeast strain, source of ABZ1QA23 and ABZ2QA23  
http://www.yeastgenome.org/strain/LalvinQA23/overview
[43]
CEN.PK113-5D MATa ura3-52 MAL2-8c SUC2 Background strain used to construct the production strains  
http://www.yeastgenome.org/strain/CENPK/overview
Euroscarf
PABA0 CEN.PK113-5D Δtrp3::natMX 
Δaro7::ARO4K229L-kanMX pSP-G1
Indole-3-glycerol-phosphate synthase and chorismate mutase  





PABA0 strain with aminodeoxychorismate synthase from AWRI1631  
and aminodeoxychorismate lyase from AWRI1631 over-expressed
This study
PABA2 PABA0 pSP-G1-ABZ1AWRI1631- 
ABZ2AWRI1631full
PABA0 strain with aminodeoxychorismate synthase from AWRI1631  
and aminodeoxychorismate lyase from AWRI1631 over-expressed
This study
PABA3 PABA0 pSP-G1-ABZ1AWRI1631- 
ABZ2S288c
PABA0 strain with aminodeoxychorismate synthase from AWRI1631  
and aminodeoxychorismate lyase from S288c over-expressed
This study
PABA4 PABA0 pSP-G1-ABZ1AWRI1631- 
ABZ2QA23
PABA0 strain with aminodeoxychorismate synthase from AWRI1631  
and aminodeoxychorismate lyase from QA23 over-expressed
This study
PABA5 PABA0 pSP-G1-ABZ1QA23-ABZ2QA23 PABA0 strain with aminodeoxychorismate synthase from QA23  
and aminodeoxychorismate lyase from QA23 over-expressed
This study
Page 14 of 16Averesch et al. Microb Cell Fact  (2016) 15:89 
The pH was controlled at 6 using 1 M H3PO4 and 10 % 
NH4OH. All fermentations were conducted at 30 °C.
Metabolite analysis
Metabolites were analysed using the same materials and 
methods as described before [8] to determine extracel-
lular concentrations of aromatics (pABA, anthranilate, 
pHBA, PHE, TYR, TRP, PEA, tryptophol and folate) 
as well as glucose, glycerol, ethanol and organic acids. 
To determination yields accurately, evaporation was 
respected: For shake-flasks evaporation of total liquid 
was estimated gravimetrically, while ethanol evaporation 
was approximated using a predetermined correlation 
between ethanol concentration and evaporation of etha-
nol from CDM + GLY/ETH over time to estimate loss of 
ethanol during fermentation incrementally. The errors of 
the yields were based on maximum and minimum yields 
determined with the boundaries for the ethanol evapo-
ration, as this exceeded standard deviation between the 
triplicates. For the bioreactor experiments the method 
described in [44] was employed to determine evapora-
tion of water and stripping of ethanol. Yields (in percent 
C-mol/C-mol) were calculated from the evaporation cor-
rected titers, while only the metabolized fraction of the 
carbon-source was respected.
13C labelled tracer cultivations were performed on 
fully labelled glucose (d-Glucose–13C6 99 atom %; Isotec, 
Germany) or on a mixture of fully labelled ethanol (13C2 
99 atom  %; Icon Isotopes, USA) and naturally enriched 
glycerol. Amino acid labellings were obtained from cell 
hydrolysates and analysed using gas chromatography—
mass spectrometry (GC–MS) described previously [9, 
31]. For this 0.2 mL of supernatant sample or 0.05 mL of 
cell hydrolysate were dried under a stream of N2 and sub-
sequently derivatized with N-methyl-tert-butyldimethyl-
silyl-trifluoroacetamide (MBDSTFA; Macherey–Nagel, 
Düren, Germany) as described before [31]. For pABA the 
ion cluster m/z = 308–315 was analysed. It represents the 
m-57 fragment (full carbon backbone of pABA) of MBD-
STFA derivatized pABA. The volatile PEA was extracted 
into hexane (equal volume to sample, vortex, decant) and 
directly injected into GC–MS. For PEA, GC–MS set-
tings were modified from the above, by applying a 1:10 
split injection. The ion cluster m/z 122-130 contained the 
full carbon backbone of PEA and was used to calculate 
enrichment. Generally, labelling distributions were cor-
rected for all naturally occurring stable isotopes in the 
derivatized molecules that do not belong to the biologi-
cal carbon backbone using the software IsoCor [45]. The 
corrected mass distributions were then used in IsoCor 
to calculate the mean enrichment of compounds using 
relative summed fractional labelling (SFL) calculated as 
follows:
where I is the intensity of the (m + i) ion in the ion clus-
ter and n the number of carbon atoms in the analysed 
mass fragment.
Quantitative real‑time PCR
To determine the relative mRNA levels of the differ-
ent over-expressed ABZ1 and ABZ2 genes, PABA 
strains were cultivated in shake-flask experiments on 
CDM  +  GLC, as described earlier. Samples (1–2  mL) 
from exponential phase (OD660  =  1) were centrifuged 
to pellet cells; cell pellets were resuspended in 1  mL 
TRIzol® (Ambion) and stored at −80  °C until extrac-
tion (no longer than 10 days). RNA was extracted using 
the PureLink® RNA Mini Kit (Ambion) in combination 
with RQ1 RNase-Free DNase (Promega) for on column 
DNAse treatment. mRNA (100–1000  ng) was reverse 
transcribed using Oligo d(T)18 primers and SuperScript® 
III reverse transcriptase (Invitrogen) in combination with 
RNase Inhibitor, Murine (NEB) according to the manu-
facturer’s instructions. qPCR reactions were carried out 
in a CFX96 Touch™ Real-Time PCR Detection System, 
using the SsoAdvanced™ Universal SYBR® Green Super-
mix (Bio-Rad) outgoing from 10 to 100 ng RNA equiva-
lent. Primers for mRNAs were unified to amplify regions 
homologous among the different ABZ1 and ABZ2 genes 
respectively, the sequences are listed in Table 4. Relative 
mRNA levels were determined by normalising to the 
housekeeping gene ALG9 [46] using the ΔCq method for 
each replicate individually as done before [8]. Relative 
expression levels were averaged for each individual gene 
among the different strains and two different sampling 
points in exponential phase. Error is standard deviation 
thereof.
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polyethylene terephthalate; pHBA: para-hydroxybenzoic acid; PHE: pheny-
lalanine; PPY: phenyl pyruvate; S3P: shikimate-3-phosphate; SFL: summed 
fractional labelling; TRP: tryptophan; TYR: tyrosine.
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